Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CD7+ Acute Leukemia”

42 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 42 results

Early research (Phase 1)Study completedNCT04840875
What this trial is testing

Phase I Clinical Trial of Autologous CD7-CAR T Cell Therapy for High-risk Acute T-cell Leukemia/lymphoma

Who this might be right for
T Cell LymphomaT-cell Leukemia
Beijing Boren Hospital 16
Early research (Phase 1)Looking for participantsNCT05043571
What this trial is testing

CARTALL: Chimeric-Antigen Receptor (CAR) T-Cell Therapy for Relapsed/ Refractory T-Lineage Acute Lymphoblastic Leukaemia

Who this might be right for
Lymphoblastic Leukemia, Acute, ChildhoodLymphoblastic LeukemiaLymphoblastic Leukemia, Acute Adult+4 more
National University Hospital, Singapore 20
Early research (Phase 1)UnknownNCT05212584
What this trial is testing

CD7 CAR-T Cell Treatment of Relapsed/Refractory CD7+ T -Acute Lymphoblastic Leukemia/ Lymphoma

Who this might be right for
Relapsed/Refractory, High Risk Hematologic MalignanciesT-ALL/Lymphoma
iCell Gene Therapeutics 24
Early research (Phase 1)Looking for participantsNCT07220993
What this trial is testing

Novel Unedited Allo Cell Therapy For High Risk T-Cell Malignancies Using CD7-Specific Car T Cells

Who this might be right for
T-cell Acute Lymphoblastic LymphomaT-non-Hodgkin LymphomaT-cell Acute Lymphoblastic Leukemia
Baylor College of Medicine 27
Very early researchStudy completedNCT05716113
What this trial is testing

CD7 CAR-T for Patients With r/r CD7+ T-ALL/T-LBL

Who this might be right for
NeoplasmsHematologic NeoplasmsNeoplasms by Site+1 more
He Huang 20
Early research (Phase 1)WithdrawnNCT05513612
What this trial is testing

Novel CAR-T Cell Therapy in the Treatment of Hematopoietic and Lymphoid Malignancies

Who this might be right for
Acute Myeloid Leukemia (AML)B-cell Non-Hodgkin's Lymphoma (B-NHL)Multiple Myeloma (MM)+2 more
Shanghai Pudong Hospital
Early research (Phase 1)Temporarily pausedNCT05377827
What this trial is testing

Dose-Escalation and Dose-Expansion Study to Evaluate the Safety and Tolerability of Anti-CD7 Allogeneic CAR T-Cells (WU-CART-007) in Patients With CD7+ Hematologic Malignancies

Who this might be right for
T-Cell Non-Hodgkin LymphomaAcute Myeloid LeukemiaAngioimmunoblastic T-cell Lymphoma+12 more
Washington University School of Medicine 6
Early research (Phase 1)Active Not RecruitingNCT03690011
What this trial is testing

Cell Therapy for High Risk T-Cell Malignancies Using CD7-Specific CAR Expressed On Autologous T Cells

Who this might be right for
T-cell Acute Lymphoblastic LymphomaT-non-Hodgkin LymphomaT-cell Acute Lymphoblastic Leukemia
Baylor College of Medicine 45
Testing effectiveness (Phase 2)Looking for participantsNCT07523555
What this trial is testing

Adaptive Dual-Target CAR-T Cells for Relapsed or Refractory Hematologic Malignancies

Who this might be right for
Relapsed/Refractory B-cell Acute Lymphoblastic LeukemiaRelapsed/Refractory B-cell Non-Hodgkin Lymphoma or CLL/SLLRelapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia+4 more
Beijing Biotech 96
Early research (Phase 1)UnknownNCT04934774
What this trial is testing

Non-gene Edited Anti-CD7 CAR T Cells for Relapsed/Refractory T Cell Malignances

Who this might be right for
T-cell Acute Lymphoblastic LeukemiaT-cell Acute Lymphoblastic LymphomaT-cell Non-Hodgkin Lymphoma
iCell Gene Therapeutics 20
Early research (Phase 1)Looking for participantsNCT07109518
What this trial is testing

UCD7 CART for Relapsed or Refractory CD7 Positive Hematologic Malignancies

Who this might be right for
Acute Myeloid Leukemia (AML)T Lymphoblastic Leukemia/Lymphoma
Institute of Hematology & Blood Diseases Hospital, China 12
Testing effectiveness (Phase 2)Looking for participantsNCT06514794
What this trial is testing

WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)

Who this might be right for
T-cell Acute Lymphoblastic LeukemiaLymphoblastic Lymphoma
Allotera Therapeutics 125
Testing effectiveness (Phase 2)WithdrawnNCT05909527
What this trial is testing

A Clinical Study of CAR-T Treating Relapsed or Refractory T Cell Lymphoblastic Acute Leukemia/ Lymphoma

Who this might be right for
T-Cell Acute Lymphocytic Leukemia
Guangzhou Bio-gene Technology Co., Ltd
Early research (Phase 1)UnknownNCT05127135
What this trial is testing

Safety and Efficacy of ThisCART7 in Patients With Refractory or Relapsed T Cell Malignancies

Who this might be right for
T-Acute Lymphoblastic LeukemiaT-cell Non-Hodgkin LymphomaT-cell Acute Lymphoblastic Lymphoma
Fundamenta Therapeutics, Ltd. 30
Not applicableStudy completedNCT04938115
What this trial is testing

Cell Therapy for CD7 Positive Acute Myeloid Leukemia or Mixed Lineage Leukemia

Who this might be right for
Leukemia, T Cell
Hebei Senlang Biotechnology Inc., Ltd. 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT04033302
What this trial is testing

Multi-CAR T Cell Therapy Targeting CD7-positive Malignancies

Who this might be right for
T-cell Acute Lymphoblastic LeukemiaT-cell Acute Lymphoblastic LymphomaAcute Myeloid Leukemia+1 more
Shenzhen Geno-Immune Medical Institute 30
Not applicableEnrolling By InvitationNCT05509855
What this trial is testing

A Long-Term Safety Follow-Up Study for Patients Treat With WU-CART-007

Who this might be right for
T-cell Acute Lymphoblastic LeukemiaT-cell Lymphoblastic Lymphoma
Allotera Therapeutics 44
Not applicableUnknownNCT04620655
What this trial is testing

RD13-01 for Patients With r/r CD7+ T-ALL/T-LBL

Who this might be right for
T Acute Lymphoblastic LeukemiaT-lymphoblastic Lymphoma
Min Xiang 24
Testing effectiveness (Phase 2)Looking for participantsNCT06420076
What this trial is testing

Sequential CAR-T Cells Therapy for CD5/CD7 Positive T-cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Using CD5/CD7-Specific CAR-T Cells

Who this might be right for
T Cell LymphomaT Cell LeukemiaT-cell Acute Lymphoblastic Leukemia+3 more
Essen Biotech 60
Not applicableNot Yet RecruitingNCT07008872
What this trial is testing

CD7 CAR-T Cell Therapy Targeting CD7-positive Relapsed/Refractory T Cell Lymphoma/Acute Leukemia

Who this might be right for
CD7+ LymphomaCD7+ Acute Leukemia
Qi deng 40
Next Page